 |
BioWorld-International-2008-08-13
Tough Biotech Lesson Learned: Fighting Big Pharma is Costly
Tough Biotech Lesson Learned: Fighting Big Pharma is Costly
LONDON - Biota Holdings Ltd. has written to shareholders to explain why it dropped a four year-long legal action against GlaxoSmithKline plc over a claim that the London-based pharma company failed to promote Biota's flu treatment Relenza properly. (BioWorld International)